Improving the Quality of Coronary Artery Bypass Grafting

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChina National Center for Cardiovascular Diseases

About this trial

This is a healthcare quality improvement study focused on increasing the utilization of arterial grafts in isolated coronary artery bypass grafting (CABG). Evidence indicates that arterial grafts, compared with venous grafts, provide superior long-term patency, which are recommended to use by the clinical practice guidelines.

In hospitals where the use of the internal mammary artery as a graft is relatively low(\<90%) among CABG patients, multiple interventions will be implemented to improve its adoption rate.

In hospitals where internal mammary artery graft utilization is already high(≥90%), various interventions will be introduced to promote the use of multiple arterial grafts (defined as the use of two or more arterial conduits).

The study targets healthcare professionals as the primary subjects of intervention, with no direct interventions applied to patients during the study period. Changes in the internal mammary artery graft utilization rate and the multiple arterial graft utilization rate before and after the intervention will serve as the primary endpoints for evaluating intervention effectiveness in the two types of hospitals, respectively.

Eligibility criteria

Qualifiers

None

Disqualifiers

50% stenosis of left subclavian artery; Pregnant women; Individuals diagnosed with mental illness or cognitive impairment (International Classification of Diseases-10 codes F01-F99); Patients considered by the investigator to have other factors unsuitable for inclusion.

Trial design

Treatments tested in this trial

  • Interventions for healthcare professionals in hospitals with low usage rates
  • Interventions for healthcare professionals in hospitals with high usage rates

Treatment groups

8,700 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

China National Center for Cardiovascular Diseases

Lead sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborator

Shandong Provincial Hospital

Collaborator

The First Affiliated Hospital with Nanjing Medical University

Collaborator

Guangdong Provincial People's Hospital

Collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborator

West China Hospital

Collaborator

First Affiliated Hospital of Wenzhou Medical University

Collaborator

Ruijin Hospital

Collaborator

The General Hospital of Northern Theater Command

Collaborator

Central China Fuwai Hospital of Zhengzhou University

Collaborator